Chemical materials

Imaprelimab (anti-CD146)

Imaprelimab (anti-CD146)

AL-AB175560 / 100ΜG
CAS No.:2014343-04-3
Add to Inquiry
Inclacumab (anti-CD62p)

Inclacumab (anti-CD62p)

AL-AB175562 / 10MG
CAS No.:1256258-86-2
Add to Inquiry
Inclacumab (anti-CD62p)

Inclacumab (anti-CD62p)

AL-AB175562 / 5MG
CAS No.:1256258-86-2
Add to Inquiry
Inclacumab (anti-CD62p)

Inclacumab (anti-CD62p)

AL-AB175562 / 1MG
CAS No.:1256258-86-2
Add to Inquiry
Inclacumab (anti-CD62p)

Inclacumab (anti-CD62p)

AL-AB175562 / 100ΜG
CAS No.:1256258-86-2
Add to Inquiry
Indusatumab vedotin (anti-GUCY2C)

Indusatumab vedotin (anti-GUCY2C)

AL-AB175563 / 10MG
CAS No.:1514889-12-3
Add to Inquiry
Indusatumab vedotin (anti-GUCY2C)

Indusatumab vedotin (anti-GUCY2C)

AL-AB175563 / 5MG
CAS No.:1514889-12-3
Add to Inquiry
Indusatumab vedotin (anti-GUCY2C)

Indusatumab vedotin (anti-GUCY2C)

AL-AB175563 / 1MG
CAS No.:1514889-12-3
Add to Inquiry
Indusatumab vedotin (anti-GUCY2C)

Indusatumab vedotin (anti-GUCY2C)

AL-AB175563 / 100ΜG
CAS No.:1514889-12-3
Add to Inquiry
Labetuzumab (anti-CEACAM5)

Labetuzumab (anti-CEACAM5)

AL-AB175569 / 10MG
CAS No.:219649-07-7
Add to Inquiry
Labetuzumab (anti-CEACAM5)

Labetuzumab (anti-CEACAM5)

AL-AB175569 / 5MG
CAS No.:219649-07-7
Add to Inquiry
Labetuzumab (anti-CEACAM5)

Labetuzumab (anti-CEACAM5)

AL-AB175569 / 1MG
CAS No.:219649-07-7
Add to Inquiry
Labetuzumab (anti-CEACAM5)

Labetuzumab (anti-CEACAM5)

AL-AB175569 / 100ΜG
CAS No.:219649-07-7
Add to Inquiry
Labetuzumab govitecan (anti-CEACAM5)

Labetuzumab govitecan (anti-CEACAM5)

AL-AB175570 / 100ΜG
CAS No.:1469876-18-3
Add to Inquiry
Labetuzumab govitecan (anti-CEACAM5)

Labetuzumab govitecan (anti-CEACAM5)

AL-AB175570 / 10MG
CAS No.:1469876-18-3
Add to Inquiry
Labetuzumab govitecan (anti-CEACAM5)

Labetuzumab govitecan (anti-CEACAM5)

AL-AB175570 / 5MG
CAS No.:1469876-18-3
Add to Inquiry
Labetuzumab govitecan (anti-CEACAM5)

Labetuzumab govitecan (anti-CEACAM5)

AL-AB175570 / 1MG
CAS No.:1469876-18-3
Add to Inquiry
Lampalizumab (anti-Complement Factor D)

Lampalizumab (anti-Complement Factor D)

AL-AB175571 / 1MG
CAS No.:1278466-20-8
Add to Inquiry
Lampalizumab (anti-Complement Factor D)

Lampalizumab (anti-Complement Factor D)

AL-AB175571 / 5MG
CAS No.:1278466-20-8
Add to Inquiry
Lampalizumab (anti-Complement Factor D)

Lampalizumab (anti-Complement Factor D)

AL-AB175571 / 10MG
CAS No.:1278466-20-8
Add to Inquiry
Lampalizumab (anti-Complement Factor D)

Lampalizumab (anti-Complement Factor D)

AL-AB175571 / 100ΜG
CAS No.:1278466-20-8
Add to Inquiry
Landogrozumab (anti-GDF8)

Landogrozumab (anti-GDF8)

AL-AB175573 / 1MG
CAS No.:1391726-30-9
Add to Inquiry
Landogrozumab (anti-GDF8)

Landogrozumab (anti-GDF8)

AL-AB175573 / 100ΜG
CAS No.:1391726-30-9
Add to Inquiry
Landogrozumab (anti-GDF8)

Landogrozumab (anti-GDF8)

AL-AB175573 / 10MG
CAS No.:1391726-30-9
Add to Inquiry
Landogrozumab (anti-GDF8)

Landogrozumab (anti-GDF8)

AL-AB175573 / 5MG
CAS No.:1391726-30-9
Add to Inquiry
Lecanemab (anti-Amyloid Beta)

Lecanemab (anti-Amyloid Beta)

AL-AB175575 / 10MG
CAS No.:1260393-98-3
Add to Inquiry
Lecanemab (anti-Amyloid Beta)

Lecanemab (anti-Amyloid Beta)

AL-AB175575 / 5MG
CAS No.:1260393-98-3
Add to Inquiry
Lecanemab (anti-Amyloid Beta)

Lecanemab (anti-Amyloid Beta)

AL-AB175575 / 100ΜG
CAS No.:1260393-98-3
Add to Inquiry
Lecanemab (anti-Amyloid Beta)

Lecanemab (anti-Amyloid Beta)

AL-AB175575 / 1MG
CAS No.:1260393-98-3
Add to Inquiry
Lenzilumab (anti-GM-CSF)

Lenzilumab (anti-GM-CSF)

AL-AB175576 / 5MG
CAS No.:1229575-09-0
Add to Inquiry
Lenzilumab (anti-GM-CSF)

Lenzilumab (anti-GM-CSF)

AL-AB175576 / 1MG
CAS No.:1229575-09-0
Add to Inquiry
Lenzilumab (anti-GM-CSF)

Lenzilumab (anti-GM-CSF)

AL-AB175576 / 10MG
CAS No.:1229575-09-0
Add to Inquiry
Lenzilumab (anti-GM-CSF)

Lenzilumab (anti-GM-CSF)

AL-AB175576 / 100ΜG
CAS No.:1229575-09-0
Add to Inquiry
lepunafusp alfa

lepunafusp alfa

AL-AB175577 / 1MG
Add to Inquiry
lepunafusp alfa

lepunafusp alfa

AL-AB175577 / 5MG
Add to Inquiry
Lifastuzumab vedotin (anti-SLC34A2)

Lifastuzumab vedotin (anti-SLC34A2)

AL-AB175578 / 1MG
CAS No.:1401812-88-1
Add to Inquiry
Lifastuzumab vedotin (anti-SLC34A2)

Lifastuzumab vedotin (anti-SLC34A2)

AL-AB175578 / 5MG
CAS No.:1401812-88-1
Add to Inquiry
Lifastuzumab vedotin (anti-SLC34A2)

Lifastuzumab vedotin (anti-SLC34A2)

AL-AB175578 / 10MG
CAS No.:1401812-88-1
Add to Inquiry
Lifastuzumab vedotin (anti-SLC34A2)

Lifastuzumab vedotin (anti-SLC34A2)

AL-AB175578 / 100ΜG
CAS No.:1401812-88-1
Add to Inquiry
Ligelizumab (anti-IgE)

Ligelizumab (anti-IgE)

AL-AB175579 / 1MG
CAS No.:1322627-61-1
Add to Inquiry
Ligelizumab (anti-IgE)

Ligelizumab (anti-IgE)

AL-AB175579 / 5MG
CAS No.:1322627-61-1
Add to Inquiry
Ligelizumab (anti-IgE)

Ligelizumab (anti-IgE)

AL-AB175579 / 10MG
CAS No.:1322627-61-1
Add to Inquiry
Ligelizumab (anti-IgE)

Ligelizumab (anti-IgE)

AL-AB175579 / 100ΜG
CAS No.:1322627-61-1
Add to Inquiry
Lilotomab (anti-TSPAN26)

Lilotomab (anti-TSPAN26)

AL-AB175580 / 100ΜG
CAS No.:1453362-55-4
Add to Inquiry
Lilotomab (anti-TSPAN26)

Lilotomab (anti-TSPAN26)

AL-AB175580 / 10MG
CAS No.:1453362-55-4
Add to Inquiry
Lilotomab (anti-TSPAN26)

Lilotomab (anti-TSPAN26)

AL-AB175580 / 5MG
CAS No.:1453362-55-4
Add to Inquiry
Lilotomab (anti-TSPAN26)

Lilotomab (anti-TSPAN26)

AL-AB175580 / 1MG
CAS No.:1453362-55-4
Add to Inquiry
Lintuzumab (anti-CD33)

Lintuzumab (anti-CD33)

AL-AB175581 / 10MG
CAS No.:166089-32-3
Add to Inquiry
Lintuzumab (anti-CD33)

Lintuzumab (anti-CD33)

AL-AB175581 / 100ΜG
CAS No.:166089-32-3
Add to Inquiry
Lintuzumab (anti-CD33)

Lintuzumab (anti-CD33)

AL-AB175581 / 5MG
CAS No.:166089-32-3
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.